USD 2.9
(-2.68%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 11.91 Million BRL | N/A |
2022 | 226.86 Million BRL | -36.96% |
2021 | 359.86 Million BRL | 172.63% |
2020 | 132 Million BRL | 314.07% |
2019 | -61.66 Million BRL | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q1 | -27.56 Million BRL | 53.36% |
2023 Q3 | -46.83 Million BRL | -130.97% |
2023 Q2 | 151.23 Million BRL | 648.59% |
2022 FY | 226.86 Million BRL | -36.96% |
2022 Q4 | -59.1 Million BRL | 77.5% |
2022 Q3 | -262.73 Million BRL | -171.75% |
2022 Q2 | 366.19 Million BRL | 112.41% |
2022 Q1 | 172.4 Million BRL | 242.07% |
2021 Q1 | 133.96 Million BRL | 296.22% |
2021 FY | 359.86 Million BRL | 172.63% |
2021 Q2 | 133.96 Million BRL | 0.0% |
2021 Q4 | -121.34 Million BRL | -162.95% |
2021 Q3 | 192.75 Million BRL | 43.89% |
2020 FY | 132 Million BRL | 314.07% |
2020 Q4 | -68.27 Million BRL | 0.0% |
2019 FY | -61.66 Million BRL | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Bioceres Crop Solutions Corp. | 44.82 Million USD | 73.425% |
Muliang Viagoo Technology, Inc. | 467.3 Thousand USD | -2448.892% |
N2OFF, Inc. | -7.57 Million USD | 257.183% |
Arcadia Biosciences, Inc. | -13.93 Million USD | 185.457% |
Yield10 Bioscience, Inc. | -14.41 Million USD | 182.618% |